SUPPORTING INFORMATION

Mutations at hypothetical binding Site 2 in insulin and insulin-like growth factors 1 and 2 elicit receptor-and hormone-specific responses
Macháčková et al. Table S1 Binding affinities and receptor activation abilities of analogs for IR-A.
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Structural characterization of the metadynamics ensembles -hydrophobic collapse and hydrogen bond analysis. Table S1 . Receptor-binding affinities of human insulin, IGF-1, IGF-2 and analogs for human IR-A in membranes of IM-9 lymphocytes and relative abilities of the hormones/analogs to stimulate phosphorylation of human IR-A in membranes of transfected mouse fibroblasts (details are provided in Methods). The Kd values or relative stimulations were obtained from at least three measurements. (n) is number of replicates. Asterisks indicate that binding of the ligand to the receptor or activation of the receptor by the ligand differs significantly from that of the native hormone (*p<0.05; **p<0.01; ***p< 0.001). In these columns for each IGF analogue their values relative to insulin are then expressed relative to native IGF-1 (100%) for IGF-1 analogs or relative to native IGF-2 (100%) for IGF2 analogs. Cells were stimulated with 10 nM ligands for 10 min. Membranes were cut at 75 kDa and 50 kDa standards and respective parts were developed with anti-phospho-IGF-1Rβ (Tyr1135/1136)/IRβ (Tyr1150/1151) antibody (Mr above 75 kDa) and with anti-actin antibody (Mr bellow 50 kDa). In some cases, cells were also stimulated with analogs that were not discussed in the manuscript. Cells were stimulated with 10 nM ligands for 10 min. Membranes were cut at 75 kDa and 50 kDa standards and respective parts were developed with anti-phospho-IGF-1Rβ (Tyr1135/1136)/IRβ (Tyr1150/1151) antibody (Mr above 75 kDa) and with anti-actin antibody (Mr bellow 50 kDa). In some cases, cells were also stimulated with analogs that were not discussed in the manuscript. 1.09
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*only well-defined parts of the structure: Ala8-Cys18, Ile43-Tyr60
Differential Contact Maps calculated from metadynamics of the insulin B-chain C-terminus opening
The inter-residue contacts with a negative difference in contact lifetime between the wild-type and mutants are those that are more frequently present in mutant compared to wild-type insulin (colored in orange in Figure S7) . A range of hydrophobic contacts between the B-chain N-terminus (PheB1, ValB2) and the A chain (LeuA13, LeuA16) were established to maintain the collapsed state for HisA10 and HisA13 mutants, as well as the closed state for the HisA17 mutant. Contacts between the B-chain N-terminus and residues in the B-chain α-helix were more frequently present in the collapsed/closed states of the Hisinsulin mutants. For example, the contacts in HisA13 mutant between residues HisB5-GlyB8, GlnB4-HisB10, GlnB4-GluB13 contributed to the partial collapse of the B-chain α-helix. For the native-like affinity ThrA12 contacts that were formed more frequently than in the wild type (for example IleA2, ValA3 with LeuB15, LeuB11) maintained the hydrophobic interface between A/B chains in a more compact state. Figure S7 . Change in total interaction time for insulin mutants calculated as the difference in fraction of time contacts are present between residues for the wild type and the mutant (a negative difference signifies a contact less frequently present in wild type or a contact gained in mutant). The residue index goes from 1-21 for A chain and 22-51 for B chain of insulin. HisA10-insulin, Left upper panel; HisA13insulin, right upper panel; HisA17-insulin, left lower panel; ThrA12-insulin, right lower panel.
HisA10 HisA13
HisA17 ThrA12
Structural characterization of the metadynamics ensembles
The insulin hydrophobic core comprises residues IleA2, ValA3, GlyB8, LeuB11, ValB12, LeuB15, PheB24 and TyrB26 (8) . We calculated its size in terms of the radius of gyration Rgyr comprising all atoms for the respective residues. The hydrophobic core is more compact for the mutants compared to the wild-type insulin, except for the HisA10-mutant which collapses to extended states (Figure S8A) . Connected to the extent of the hydrophobic collapse, we observed different protein-water hydrogen bonding local to the point of mutation. The number of water-protein hydrogen bonds was determined for a shell of the radius 1 nm around the Cα (CA) atom of a mutated residue. With OH and NH groups regarded as donors and O and N atoms as acceptors, the donor-acceptor cutoff distance was set to 0.35 nm and the angle hydrogendonor-acceptor to 30°. The number of water-protein H-bonds in a sphere of a 1 nm radius around the Cα atom of a mutated/wild-type residue is plotted in Figure S8B comparing the HisA17-mutant and ThrA12mutant in red to wild-type native insulin in black. The dynamics of H-bond formation is more stable in the closed compact state of HisA17-mutant. On the other hand, the bulkier ThrA12 is buried inside the core and forms less H-bonds with water than the wild-type SerA12.
A B Figure S8 . A. Free energy profiles with respect to the radius of gyration of residues defining the hydrophobic core. B. The number of protein-solvent hydrogen bonds in the sphere of 1 nm around Cα atoms of mutated residues: Cα (ThrA12) in ThrA12-insulin mutant and Cα (SerA12) in wild-type insulin (up), Cα (HisA17) in HisA17-insulin mutant and Cα (GluA17) in native insulin (down). Insulin wt is a native wild-type insulin.
